Mk. Sgagias et al., UP-REGULATION OF DF3, IN ASSOCIATION WITH ICAM-1 AND MHC CLASS-II BY IFN-GAMMA IN SHORT-TERM HUMAN MAMMARY-CARCINOMA CELL-CULTURES, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(3), 1996, pp. 177-185
Citations number
20
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging","Pharmacology & Pharmacy
This study was designed to determine whether in vitro exposure of isol
ated short-term human primary and metastatic breast tumor cell culture
s to interferon-gamma (IFN-gamma) could enhance expression of the brea
st tumor associated DF3 antigen in association with the intercellular
adhesion molecule 1 (ICAM-1) and MHC class II molecules. Cell cultures
were established from primary solid tumors and metastatic cells as pr
eviously described (Sgagias et al., 1995). Data show that recombinant
human IFN-gamma treatment in vitro, dramatically increased the breast
tumor associated DF3 antigen, in association with ICAM-1, and MHC clas
s II antigens in primary breast cancer cell cultures. All primary brea
st tumor cell cultures constitutively expressed high levels of HLA-cla
ss I antigen. Metastatic breast cancer cell cultures expressed high le
vels of DF3 and recombinant human IFN-gamma treatment, in vitro, upreg
ulated ICAM-1 and MHC class II antigens before and after passage of th
e metastatic cells through the nude mouse. Metastatic breast cancer ce
lls similar to primary breast cancer cells constitutively expressed hi
gh levels of MHC class I antigens. In addition, three LAK cell lines s
ignificantly lysed the primary and the metastatic breast tumor cell cu
ltures to the same degree before and after passage of the metastatic c
ancer cells through the nude mouse. These data indicate the upregulati
on of the breast tumor associated DF3 antigen in vitro after IFN-gamma
treatment and its persistence in vivo, after passage of the metastati
c breast cancer cells through the nude mouse. The ability of IFN-gamma
to upregulate the breast tumor associated DF3 antigen in association
with the ICAM-1 and HLA class II antigens may play an important role i
n eliciting an immune response which may contribute to the immunodiagn
osis, and immunotherapy of breast cancer.